Fed. Circ. Affirms Warner Chilcott's Actonel Patents Invalid
By Aaron Vehling ( November 18, 2014, 5:09 PM EST) -- The Federal Circuit on Tuesday ruled that two patents for Warner Chilcott Co. LLC's osteoporosis drug Actonel were invalid as obvious, affirming a lower court decision in favor of generic-drug makers such as Teva Pharmaceuticals USA Inc. in a consolidated infringement suit filed by Warner Chilcott and Hoffmann-La Roche Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.